Hemoperfusion Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Product Type (Charcoal Hemoperfusion, Certain Resins Hemoperfusion, Polymer Hemoperfusion); Application (Hepatic Encephalopathy, Overdose, Specific Intoxications, Certain Autoimmune Diseases, Other)
Report Code: TIPRE00009799 No. of Pages: 150 Category: Medical Device Status: Upcoming
MARKET INTRODUCTION
Hemoperfusion is described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. This method was introduced in 1965 as a method for removing toxic substances from the body. It is done by lowering the blood concentration of several xenobiotic agents when they are the cause of intoxication. Adsorption is a method in which molecules or particles of one substance are attracted to the surface of solid material and held on there. These solid materials are called sorbents. In hemoperfusion, whole blood is passed through a column that contains fixed adsorbent particles. Toxins with molecular weights ranging from 100 to 40,000 Daltons bind to the particles and are removed as blood exits the column. Higher-molecular-weight solutes are adsorbed less efficiently. The sorbents most commonly used in hemoperfusion are resins and various forms of activated carbon or charcoal.
MARKET DYNAMICS
The rising number of blood and blood-related disorders and increasing use of adsorbent substance techniques to remove toxic substances and poisons will spur the demand of the hemoperfusion market. Fluctuations in the price of the upstream product such as the major raw materials polypropylene, polycarbonate, membrane materials, activated carbon, etc. used in hemoperfusion will impact on the production cost of hemoperfusion. Hence, it will affect the price of hemoperfusion, which could affect the market value of the hemoperfusion market. Hemoperfusion manufacturers are trying to produce many more types of hemoperfusion for other different diseases. However, the risks of infection, blood clotting, destruction of blood platelets, and organ failure associated with hemoperfusion may restrict the adoption of this technology that may hinder the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Hemoperfusion Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of hemoperfusion market with detailed market segmentation by product, application, and geography. The global hemoperfusion Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading hemoperfusion market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global hemoperfusion market is segmented on the product, and application. Based on product, the global hemoperfusion market is segmented into charcoal hemoperfusion, certain resins hemoperfusion, and polymer hemoperfusion. Based on the application, the hemoperfusion market is segmented hepatic encephalopathy, overdose, specific intoxications, certain autoimmune diseases, and other.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hemoperfusion market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hemoperfusion market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting hemoperfusion market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hemoperfusion market in these regions.
The reports cover key developments in the hemoperfusion market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from hemoperfusion market are anticipated to lucrative growth opportunities in the future with the rising demand for hemoperfusion in the global market. Below mentioned is the list of few companies engaged in the hemoperfusion market.
The report also includes the profiles of key hemoperfusion market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Hemoperfusion is described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. This method was introduced in 1965 as a method for removing toxic substances from the body. It is done by lowering the blood concentration of several xenobiotic agents when they are the cause of intoxication. Adsorption is a method in which molecules or particles of one substance are attracted to the surface of solid material and held on there. These solid materials are called sorbents. In hemoperfusion, whole blood is passed through a column that contains fixed adsorbent particles. Toxins with molecular weights ranging from 100 to 40,000 Daltons bind to the particles and are removed as blood exits the column. Higher-molecular-weight solutes are adsorbed less efficiently. The sorbents most commonly used in hemoperfusion are resins and various forms of activated carbon or charcoal.
MARKET DYNAMICS
The rising number of blood and blood-related disorders and increasing use of adsorbent substance techniques to remove toxic substances and poisons will spur the demand of the hemoperfusion market. Fluctuations in the price of the upstream product such as the major raw materials polypropylene, polycarbonate, membrane materials, activated carbon, etc. used in hemoperfusion will impact on the production cost of hemoperfusion. Hence, it will affect the price of hemoperfusion, which could affect the market value of the hemoperfusion market. Hemoperfusion manufacturers are trying to produce many more types of hemoperfusion for other different diseases. However, the risks of infection, blood clotting, destruction of blood platelets, and organ failure associated with hemoperfusion may restrict the adoption of this technology that may hinder the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Hemoperfusion Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of hemoperfusion market with detailed market segmentation by product, application, and geography. The global hemoperfusion Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading hemoperfusion market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global hemoperfusion market is segmented on the product, and application. Based on product, the global hemoperfusion market is segmented into charcoal hemoperfusion, certain resins hemoperfusion, and polymer hemoperfusion. Based on the application, the hemoperfusion market is segmented hepatic encephalopathy, overdose, specific intoxications, certain autoimmune diseases, and other.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hemoperfusion market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hemoperfusion market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting hemoperfusion market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hemoperfusion market in these regions.
The reports cover key developments in the hemoperfusion market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from hemoperfusion market are anticipated to lucrative growth opportunities in the future with the rising demand for hemoperfusion in the global market. Below mentioned is the list of few companies engaged in the hemoperfusion market.
The report also includes the profiles of key hemoperfusion market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Baxter
- Asahi Kasei Medical Co., Ltd.
- TORAY MEDICAL CO,.LTD.
- Biosun Corporation
- Jafron Biomedical Co.
- Kaneka Pharma
- CytoSorbents Corporation
- Medtronic
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hemoperfusion Market - By Product Type
1.3.2 Hemoperfusion Market - By Application
1.3.3 Hemoperfusion Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEMOPERFUSION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEMOPERFUSION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HEMOPERFUSION MARKET - GLOBAL MARKET ANALYSIS
6.1. HEMOPERFUSION - GLOBAL MARKET OVERVIEW
6.2. HEMOPERFUSION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HEMOPERFUSION MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHARCOAL HEMOPERFUSION
7.3.1. Overview
7.3.2. Charcoal Hemoperfusion Market Forecast and Analysis
7.4. CERTAIN RESINS HEMOPERFUSION
7.4.1. Overview
7.4.2. Certain Resins Hemoperfusion Market Forecast and Analysis
7.5. POLYMER HEMOPERFUSION
7.5.1. Overview
7.5.2. Polymer Hemoperfusion Market Forecast and Analysis
8. HEMOPERFUSION MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEPATIC ENCEPHALOPATHY
8.3.1. Overview
8.3.2. Hepatic Encephalopathy Market Forecast and Analysis
8.4. OVERDOSE
8.4.1. Overview
8.4.2. Overdose Market Forecast and Analysis
8.5. SPECIFIC INTOXICATIONS
8.5.1. Overview
8.5.2. Specific Intoxications Market Forecast and Analysis
8.6. CERTAIN AUTOIMMUNE DISEASES
8.6.1. Overview
8.6.2. Certain Autoimmune Diseases Market Forecast and Analysis
8.7. OTHER
8.7.1. Overview
8.7.2. Other Market Forecast and Analysis
9. HEMOPERFUSION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Hemoperfusion Market Overview
9.1.2 North America Hemoperfusion Market Forecasts and Analysis
9.1.3 North America Hemoperfusion Market Forecasts and Analysis - By Product Type
9.1.4 North America Hemoperfusion Market Forecasts and Analysis - By Application
9.1.5 North America Hemoperfusion Market Forecasts and Analysis - By Countries
9.1.5.1 United States Hemoperfusion Market
9.1.5.1.1 United States Hemoperfusion Market by Product Type
9.1.5.1.2 United States Hemoperfusion Market by Application
9.1.5.2 Canada Hemoperfusion Market
9.1.5.2.1 Canada Hemoperfusion Market by Product Type
9.1.5.2.2 Canada Hemoperfusion Market by Application
9.1.5.3 Mexico Hemoperfusion Market
9.1.5.3.1 Mexico Hemoperfusion Market by Product Type
9.1.5.3.2 Mexico Hemoperfusion Market by Application
9.2. EUROPE
9.2.1 Europe Hemoperfusion Market Overview
9.2.2 Europe Hemoperfusion Market Forecasts and Analysis
9.2.3 Europe Hemoperfusion Market Forecasts and Analysis - By Product Type
9.2.4 Europe Hemoperfusion Market Forecasts and Analysis - By Application
9.2.5 Europe Hemoperfusion Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Hemoperfusion Market
9.2.5.1.1 Germany Hemoperfusion Market by Product Type
9.2.5.1.2 Germany Hemoperfusion Market by Application
9.2.5.2 France Hemoperfusion Market
9.2.5.2.1 France Hemoperfusion Market by Product Type
9.2.5.2.2 France Hemoperfusion Market by Application
9.2.5.3 Italy Hemoperfusion Market
9.2.5.3.1 Italy Hemoperfusion Market by Product Type
9.2.5.3.2 Italy Hemoperfusion Market by Application
9.2.5.4 Spain Hemoperfusion Market
9.2.5.4.1 Spain Hemoperfusion Market by Product Type
9.2.5.4.2 Spain Hemoperfusion Market by Application
9.2.5.5 United Kingdom Hemoperfusion Market
9.2.5.5.1 United Kingdom Hemoperfusion Market by Product Type
9.2.5.5.2 United Kingdom Hemoperfusion Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Hemoperfusion Market Overview
9.3.2 Asia-Pacific Hemoperfusion Market Forecasts and Analysis
9.3.3 Asia-Pacific Hemoperfusion Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Hemoperfusion Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Hemoperfusion Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Hemoperfusion Market
9.3.5.1.1 Australia Hemoperfusion Market by Product Type
9.3.5.1.2 Australia Hemoperfusion Market by Application
9.3.5.2 China Hemoperfusion Market
9.3.5.2.1 China Hemoperfusion Market by Product Type
9.3.5.2.2 China Hemoperfusion Market by Application
9.3.5.3 India Hemoperfusion Market
9.3.5.3.1 India Hemoperfusion Market by Product Type
9.3.5.3.2 India Hemoperfusion Market by Application
9.3.5.4 Japan Hemoperfusion Market
9.3.5.4.1 Japan Hemoperfusion Market by Product Type
9.3.5.4.2 Japan Hemoperfusion Market by Application
9.3.5.5 South Korea Hemoperfusion Market
9.3.5.5.1 South Korea Hemoperfusion Market by Product Type
9.3.5.5.2 South Korea Hemoperfusion Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Hemoperfusion Market Overview
9.4.2 Middle East and Africa Hemoperfusion Market Forecasts and Analysis
9.4.3 Middle East and Africa Hemoperfusion Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Hemoperfusion Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Hemoperfusion Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Hemoperfusion Market
9.4.5.1.1 South Africa Hemoperfusion Market by Product Type
9.4.5.1.2 South Africa Hemoperfusion Market by Application
9.4.5.2 Saudi Arabia Hemoperfusion Market
9.4.5.2.1 Saudi Arabia Hemoperfusion Market by Product Type
9.4.5.2.2 Saudi Arabia Hemoperfusion Market by Application
9.4.5.3 U.A.E Hemoperfusion Market
9.4.5.3.1 U.A.E Hemoperfusion Market by Product Type
9.4.5.3.2 U.A.E Hemoperfusion Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Hemoperfusion Market Overview
9.5.2 South and Central America Hemoperfusion Market Forecasts and Analysis
9.5.3 South and Central America Hemoperfusion Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Hemoperfusion Market Forecasts and Analysis - By Application
9.5.5 South and Central America Hemoperfusion Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Hemoperfusion Market
9.5.5.1.1 Brazil Hemoperfusion Market by Product Type
9.5.5.1.2 Brazil Hemoperfusion Market by Application
9.5.5.2 Argentina Hemoperfusion Market
9.5.5.2.1 Argentina Hemoperfusion Market by Product Type
9.5.5.2.2 Argentina Hemoperfusion Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. HEMOPERFUSION MARKET, KEY COMPANY PROFILES
11.1. BAXTER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASAHI KASEI MEDICAL CO., LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. TORAY MEDICAL CO,.LTD.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIOSUN CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JAFRON BIOMEDICAL CO.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KANEKA PHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CYTOSORBENTS CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MEDTRONIC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. FRESENIUS SE AND CO. KGAA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. B. BRAUN MELSUNGEN AG
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hemoperfusion Market - By Product Type
1.3.2 Hemoperfusion Market - By Application
1.3.3 Hemoperfusion Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEMOPERFUSION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEMOPERFUSION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HEMOPERFUSION MARKET - GLOBAL MARKET ANALYSIS
6.1. HEMOPERFUSION - GLOBAL MARKET OVERVIEW
6.2. HEMOPERFUSION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HEMOPERFUSION MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHARCOAL HEMOPERFUSION
7.3.1. Overview
7.3.2. Charcoal Hemoperfusion Market Forecast and Analysis
7.4. CERTAIN RESINS HEMOPERFUSION
7.4.1. Overview
7.4.2. Certain Resins Hemoperfusion Market Forecast and Analysis
7.5. POLYMER HEMOPERFUSION
7.5.1. Overview
7.5.2. Polymer Hemoperfusion Market Forecast and Analysis
8. HEMOPERFUSION MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEPATIC ENCEPHALOPATHY
8.3.1. Overview
8.3.2. Hepatic Encephalopathy Market Forecast and Analysis
8.4. OVERDOSE
8.4.1. Overview
8.4.2. Overdose Market Forecast and Analysis
8.5. SPECIFIC INTOXICATIONS
8.5.1. Overview
8.5.2. Specific Intoxications Market Forecast and Analysis
8.6. CERTAIN AUTOIMMUNE DISEASES
8.6.1. Overview
8.6.2. Certain Autoimmune Diseases Market Forecast and Analysis
8.7. OTHER
8.7.1. Overview
8.7.2. Other Market Forecast and Analysis
9. HEMOPERFUSION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Hemoperfusion Market Overview
9.1.2 North America Hemoperfusion Market Forecasts and Analysis
9.1.3 North America Hemoperfusion Market Forecasts and Analysis - By Product Type
9.1.4 North America Hemoperfusion Market Forecasts and Analysis - By Application
9.1.5 North America Hemoperfusion Market Forecasts and Analysis - By Countries
9.1.5.1 United States Hemoperfusion Market
9.1.5.1.1 United States Hemoperfusion Market by Product Type
9.1.5.1.2 United States Hemoperfusion Market by Application
9.1.5.2 Canada Hemoperfusion Market
9.1.5.2.1 Canada Hemoperfusion Market by Product Type
9.1.5.2.2 Canada Hemoperfusion Market by Application
9.1.5.3 Mexico Hemoperfusion Market
9.1.5.3.1 Mexico Hemoperfusion Market by Product Type
9.1.5.3.2 Mexico Hemoperfusion Market by Application
9.2. EUROPE
9.2.1 Europe Hemoperfusion Market Overview
9.2.2 Europe Hemoperfusion Market Forecasts and Analysis
9.2.3 Europe Hemoperfusion Market Forecasts and Analysis - By Product Type
9.2.4 Europe Hemoperfusion Market Forecasts and Analysis - By Application
9.2.5 Europe Hemoperfusion Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Hemoperfusion Market
9.2.5.1.1 Germany Hemoperfusion Market by Product Type
9.2.5.1.2 Germany Hemoperfusion Market by Application
9.2.5.2 France Hemoperfusion Market
9.2.5.2.1 France Hemoperfusion Market by Product Type
9.2.5.2.2 France Hemoperfusion Market by Application
9.2.5.3 Italy Hemoperfusion Market
9.2.5.3.1 Italy Hemoperfusion Market by Product Type
9.2.5.3.2 Italy Hemoperfusion Market by Application
9.2.5.4 Spain Hemoperfusion Market
9.2.5.4.1 Spain Hemoperfusion Market by Product Type
9.2.5.4.2 Spain Hemoperfusion Market by Application
9.2.5.5 United Kingdom Hemoperfusion Market
9.2.5.5.1 United Kingdom Hemoperfusion Market by Product Type
9.2.5.5.2 United Kingdom Hemoperfusion Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Hemoperfusion Market Overview
9.3.2 Asia-Pacific Hemoperfusion Market Forecasts and Analysis
9.3.3 Asia-Pacific Hemoperfusion Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Hemoperfusion Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Hemoperfusion Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Hemoperfusion Market
9.3.5.1.1 Australia Hemoperfusion Market by Product Type
9.3.5.1.2 Australia Hemoperfusion Market by Application
9.3.5.2 China Hemoperfusion Market
9.3.5.2.1 China Hemoperfusion Market by Product Type
9.3.5.2.2 China Hemoperfusion Market by Application
9.3.5.3 India Hemoperfusion Market
9.3.5.3.1 India Hemoperfusion Market by Product Type
9.3.5.3.2 India Hemoperfusion Market by Application
9.3.5.4 Japan Hemoperfusion Market
9.3.5.4.1 Japan Hemoperfusion Market by Product Type
9.3.5.4.2 Japan Hemoperfusion Market by Application
9.3.5.5 South Korea Hemoperfusion Market
9.3.5.5.1 South Korea Hemoperfusion Market by Product Type
9.3.5.5.2 South Korea Hemoperfusion Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Hemoperfusion Market Overview
9.4.2 Middle East and Africa Hemoperfusion Market Forecasts and Analysis
9.4.3 Middle East and Africa Hemoperfusion Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Hemoperfusion Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Hemoperfusion Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Hemoperfusion Market
9.4.5.1.1 South Africa Hemoperfusion Market by Product Type
9.4.5.1.2 South Africa Hemoperfusion Market by Application
9.4.5.2 Saudi Arabia Hemoperfusion Market
9.4.5.2.1 Saudi Arabia Hemoperfusion Market by Product Type
9.4.5.2.2 Saudi Arabia Hemoperfusion Market by Application
9.4.5.3 U.A.E Hemoperfusion Market
9.4.5.3.1 U.A.E Hemoperfusion Market by Product Type
9.4.5.3.2 U.A.E Hemoperfusion Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Hemoperfusion Market Overview
9.5.2 South and Central America Hemoperfusion Market Forecasts and Analysis
9.5.3 South and Central America Hemoperfusion Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Hemoperfusion Market Forecasts and Analysis - By Application
9.5.5 South and Central America Hemoperfusion Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Hemoperfusion Market
9.5.5.1.1 Brazil Hemoperfusion Market by Product Type
9.5.5.1.2 Brazil Hemoperfusion Market by Application
9.5.5.2 Argentina Hemoperfusion Market
9.5.5.2.1 Argentina Hemoperfusion Market by Product Type
9.5.5.2.2 Argentina Hemoperfusion Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. HEMOPERFUSION MARKET, KEY COMPANY PROFILES
11.1. BAXTER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASAHI KASEI MEDICAL CO., LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. TORAY MEDICAL CO,.LTD.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIOSUN CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JAFRON BIOMEDICAL CO.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KANEKA PHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CYTOSORBENTS CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MEDTRONIC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. FRESENIUS SE AND CO. KGAA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. B. BRAUN MELSUNGEN AG
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Baxter
2. Asahi Kasei Medical Co., Ltd.
3. TORAY MEDICAL CO,.LTD.
4. Biosun Corporation
5. Jafron Biomedical Co.
6. Kaneka Pharma
7. CytoSorbents Corporation
8. Medtronic
9. Fresenius SE & Co. KGaA
10. B. Braun Melsungen AG
1. Baxter
2. Asahi Kasei Medical Co., Ltd.
3. TORAY MEDICAL CO,.LTD.
4. Biosun Corporation
5. Jafron Biomedical Co.
6. Kaneka Pharma
7. CytoSorbents Corporation
8. Medtronic
9. Fresenius SE & Co. KGaA
10. B. Braun Melsungen AG